In the ABL/BCR fusion proteins, the N-terminus of BCR is substituted by the first exon of abl. The differences between ALL- and CML-specific ABL/BCR lie in the presence of the DH and PH domains. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.